EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm in patients with newly diagnosed stage I–III breast cancer who undergo surgery as first‐line treatment

Lea Haverbeck Simon, Carson Saviers-Steiger, Emily R Dunston, Patrick Galyean, Elisabeth R Kimball, Justine Mendez, Susan L Zickmund, Pamela A Hansen, Cornelia M Ulrich iD, Paul C LaStayo, David Steinberg, Christopher S Noren und 7 weitere

Cancer · 2025

DOI: 10.1002/cncr.35798 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cancer, 2025. Verfasst von Lea Haverbeck Simon und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Control and Population Sciences Program, Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Exercise Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, 5 for the Fight, a Qualtrics Inc.-sponsored nonprofit organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This pilot, mixed‐methods, randomized controlled trial determined the feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm. CORE was designed to connect patients with newly diagnosed breast cancer to exercise and rehabilitation services from the time of diagnosis throughout cancer care.

Methods

In total, 72 patients with newly diagnosed, stage I–III breast cancer who required surgery as first‐line treatment were randomized 2:1 to CORE or standard of care. CORE included a triaging tool of two questionnaires regarding self‐reported exercise (the Godin Leisure Time physical activity questionnaire) and functional status (the Patient‐Reported Outcomes Measurement Information System physical function questionnaire), which were administered at the check‐in desk for routine breast surgical oncology clinic visits at the initial surgical consultation, postoperatively, and 24 weeks after surgery. Responses to questionnaires in the triaging tool triaged participants to one of three pathways within the algorithm: exercise service, rehabilitation service, or exercise self‐management (not a service). Service pathways required referral by clinic staff. Feasibility was determined based on completing the triaging tool (≥66%) and referral completion (≥50%) at the initial surgical consultation visit. Acceptability was determined by four study participant focus groups and one clinic team focus group (≥50% positive response).

Results

Ninety‐three percent of participants in CORE ( n = 40) completed the triaging tool. Among those triaged to a service pathway ( n = 29), 62% completed their referral. Focus group feedback was primarily positive.

Conclusions

The CORE clinical workflow algorithm is feasible and acceptable among women who have newly diagnosed stage I–III breast cancer with plans for surgery as first‐line treatment. CORE was also acceptable among clinic staff. Clinical Trials Registration NCT04594473

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsExercise TherapyHumansFemaleMiddle AgedAlgorithmsFeasibility StudiesAgedPilot ProjectsAdultSurveys and QuestionnairesWorkflowNeoplasm StagingExercisePatient Reported Outcome MeasuresPatient Acceptance of Health Care

Stichwörter der Autor:innen

breast cancercancer rehabilitationclinical workflowexercise oncologyhealth services

Autor:innen und Institutionen

  • Cancer Control and Population Sciences Program, Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, USA.
  • The Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, USA.
  • Department of Health and Kinesiology, University of Utah, Salt Lake City, Utah, USA.
  • Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA.
  • Department of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, Utah, USA.

ORCID-Profile: Cornelia M Ulrich, Adriana M Coletta

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • 5 for the Fight, a Qualtrics Inc.-sponsored nonprofit organization

Zitieren

APA

Simon, L. H., Saviers-Steiger, C., Dunston, E. R., Galyean, P., Kimball, E. R., Mendez, J., Zickmund, S. L., Hansen, P. A., Ulrich, C. M., LaStayo, P. C., Steinberg, D., Noren, C. S., Finch, A., Seckinger, L., Braun, E., Chipman, J., Brownson, K. E., Oza, S., & Coletta, A. M. (2025). Feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm in patients with newly diagnosed stage I–III breast cancer who undergo surgery as first‐line treatment. Cancer. https://doi.org/10.1002/cncr.35798

Vancouver

Simon LH, Saviers-Steiger C, Dunston ER, Galyean P, Kimball ER, Mendez J, et al. Feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm in patients with newly diagnosed stage I–III breast cancer who undergo surgery as first‐line treatment. Cancer. 2025. doi:10.1002/cncr.35798

BibTeX
@article{Simon2025,
  author = {Simon, Lea Haverbeck and Saviers-Steiger, Carson and Dunston, Emily R and Galyean, Patrick and Kimball, Elisabeth R and Mendez, Justine and Zickmund, Susan L and Hansen, Pamela A and Ulrich, Cornelia M and LaStayo, Paul C and Steinberg, David and Noren, Christopher S and Finch, A'Lisha and Seckinger, Leanne and Braun, Emma and Chipman, Jonathan and Brownson, Kirstyn E and Oza, Sonal and Coletta, Adriana M},
  title = {Feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm in patients with newly diagnosed stage I–III breast cancer who undergo surgery as first‐line treatment},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.35798}
}
Kostenlos starten →